The company utilizes third-party contract manufacturing organizations (CMOs) to produce its product candidates, which must adhere to FDA and international regulatory requirements, including current Good Manufacturing Practice (cGMP) standards. Noncompliance by these CMOs could result in delays to clinical trials, regulatory approvals, and commercialization. The company relies on sole source and limited source suppliers for certain drug substances, drug products, raw materials, samples, components, and other materials. Challenges faced by CMOs, such as resource limitations, labor disputes, or political instability, may disrupt supply. Proposed U.S. legislation, including the BIOSECURE Act, could limit collaboration with certain Chinese biotechnology companies, potentially increasing costs or reducing material availability, thereby affecting clinical trials and business operations. The company does not currently maintain long-term supply contracts with its CMOs.
Acelyrin Inc's Comment on Supply Chain
The company utilizes third-party contract manufacturing organizations (CMOs) to produce its product candidates, which must adhere to FDA and international regulatory requirements, including current Good Manufacturing Practice (cGMP) standards. Noncompliance by these CMOs could result in delays to clinical trials, regulatory approvals, and commercialization. The company relies on sole source and limited source suppliers for certain drug substances, drug products, raw materials, samples, components, and other materials. Challenges faced by CMOs, such as resource limitations, labor disputes, or political instability, may disrupt supply. Proposed U.S. legislation, including the BIOSECURE Act, could limit collaboration with certain Chinese biotechnology companies, potentially increasing costs or reducing material availability, thereby affecting clinical trials and business operations. The company does not currently maintain long-term supply contracts with its CMOs.
Sources:
Acelyrin Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Acelyrin Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
